Osaka, Japan (December 11, 2025) – Linical, a leader in clinical research and development services, is proud to announce that we have been named CRO Company of the Year in the 2025 Global Excellence Awards presented by Global Health & Pharma Magazine. This award spotlights organizations around the world delivering exceptional performance and high-impact services in the health, pharmaceutical, and life sciences sectors.
The Global Excellence Awards recognize companies and individuals for outstanding achievements across a broad set of categories, with winners selected on criteria such as innovation, quality, customer service, and global footprint. Linical’s recognition as CRO Company of the Year underscores our enduring commitment to scientific rigor, operational excellence, and client-focused solutions.
“Our 20-year legacy in clinical research has been built on a foundation of integrity, collaboration, and continuous improvement across hundreds of clinical trials worldwide,” said Clareece West, President and CCO of Linical’s Western Region. “Being honored by Global Health & Pharma Magazine as the 2025 CRO Company of the Year is deeply gratifying. It affirms the dedication of our global teams, the trust of our clients, and the positive impact of the medicines we help bring to patients.”
Since our founding in 2005, Linical has expanded from our earliest operations into a full-service Contract Research Organization (CRO) supporting biopharmaceutical clients across all phases of clinical research. Over the past two decades, Linical has executed trials in over 40 countries across the globe, built regulatory and clinical operations expertise in emerging markets, and invested heavily in technologies that enhance data integrity, patient safety, and trial efficiency.
Some of the hallmarks of Linical’s services and philosophy include:
- Global reach & local insight: combining centralized management with on-the-ground presence in key regions to navigate regulatory, cultural, and logistical challenges
- Quality by design: embedding risk mitigation, monitoring, and data quality controls at every stage
- Innovation-driven solutions: adopting digital tools, artificial intelligence (AI), eClinical platforms, adaptive trial design methods, and decentralized clinical trial capabilities
- Client partnership: tailoring services and strategy to each sponsor’s objectives and pipeline needs
- Patient-centricity: prioritizing patient recruitment, retention, safety monitoring, and ethical oversight
Winning the Global Excellence Award further solidifies Linical’s reputation as a trusted, high-performing partner in the global clinical research landscape. The award follows a year of strong growth, new strategic alliances, and expanded capabilities in cell & gene therapy, rare disease, and decentralized trials.
About Global Health & Pharma Magazine – Global Excellence Awards
The Global Excellence Awards are an annual initiative by Global Health & Pharma Magazine to acknowledge and celebrate organizations and individuals that are driving innovation, quality, and impact in the global health and pharmaceutical industries. Winners are selected through a rigorous process evaluating operational performance, customer satisfaction, thought leadership, and market influence.
About Linical
Linical is a global provider of clinical research services, supporting biopharmaceutical companies in bringing innovative therapies to patients across APAC, Europe, and North America. With a focus on quality, technology, and patient wellbeing, Linical delivers tailored solutions for clinical trials across all phases and numerous therapeutic areas.
Media Contacts:
Alison Cundari
Senior Director, Marketing and Corporate Communications